What were Teradyne's key financial results for the quarter ended June 30, 2002?

The Form 10-Q for the period ended June 30, 2002, contains the Condensed Consolidated Statements of Operations, which detail the company's revenues, cost of sales, operating expenses, and net income for the three and six months ended June 30, 2002. Investors would need to refer to these statements within the filing for specific figures and trends.

How did Teradyne's financial position change from the end of 2001 to June 30, 2002?

The Condensed Consolidated Balance Sheets as of June 30, 2002, and December 31, 2001, provide a comparative view of Teradyne's assets, liabilities, and equity. This allows investors to assess changes in the company's cash, receivables, inventory, debt, and overall balance sheet structure over the period.

What are the main drivers of Teradyne's performance according to management?

The 'Management's Discussion and Analysis of Financial Condition and Results of Operations' section (Item 2) is the primary source for understanding management's perspective on the company's performance. It typically discusses revenue trends, factors affecting profitability, liquidity, capital resources, and any significant events or uncertainties impacting the business.

Does the report disclose any significant market risks faced by Teradyne?

Yes, Item 3 of Part I, 'Quantitative and Qualitative Disclosures about Market Risk,' addresses the company's exposure to market risks such as interest rate risk, foreign currency exchange risk, and equity price risk, and how the company manages these exposures.

TER 10-Q Quarterly Report Q2 FY2002 — Revenue, Net Income, EPS

Summary

Teradyne, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2002. This filing provides investors with a look into the company's financial performance and position during the second quarter of 2002. Key financial statements, including consolidated balance sheets, statements of operations, and cash flows, are presented for the relevant periods, offering insights into revenue, profitability, and cash generation. Management's Discussion and Analysis (MD&A) section details the operational and financial factors influencing these results, providing context for investors to understand the company's strategies and outlook. Investors should pay close attention to the trends in Teradyne's revenues and net income as presented in the Statements of Operations, as well as the company's cash position and debt levels shown in the Balance Sheets. The MD&A will be crucial for understanding the drivers behind any changes in these metrics, potential risks, and management's plans for the future. This report serves as an important update on the company's ongoing business operations and financial health in the semiconductor test equipment industry.

Key Highlights

1The report covers the quarterly period ended June 30, 2002, providing updated financial information for investors.
2Key financial statements include Condensed Consolidated Balance Sheets, Statements of Operations, and Statements of Cash Flows.
3Detailed notes to the financial statements are provided for a deeper understanding of accounting policies and significant transactions.
4Management's Discussion and Analysis (MD&A) offers management's perspective on the company's financial condition and results of operations.
5The filing includes quantitative and qualitative disclosures about market risk, which is important for assessing potential financial exposures.
6Information on legal proceedings and submission of matters to a vote of security holders is also presented in Part II of the report.
7As of July 26, 2002, Teradyne had approximately 183,056,306 shares of Common Stock outstanding.

TERADYNE, INC Quarterly Report for Q2 Ended Jun 30, 2002

Summary

Key Highlights

Frequently Asked Questions